Show Notes
According to a KFF poll, about one in eight, or 12%, of adults in the United States have used a GLP-1 medicine like Ozempic, Trulicity, Victoza, Mounjaro, Wegovy, or Zepbound. These drugs were originally developed to treat diabetes, but quickly started being prescribed for weight loss and other uses.
While they seem like wonder drugs, GLP-1 medicines do cause side effects and have risks. Nausea, vomiting, diarrhea, and constipation are common side effects. The drugs also can cause dizziness, headaches, and elevated heartbeat.
Dr. Neil Iyengar is a breast medical oncologist who studies how diet and exercise can improve quality of life for people with breast cancer. He’s also prescribed GLP-1 medicines for the people he cares for.
Listen to the episode to hear Dr. Iyengar explain:
how GLP-1 medicines work
the risks these drugs may pose for people receiving chemotherapy, immunotherapy, or a CDK4/6 inhibitor
why he works closely with a weight loss specialist or endocrinologist when prescribing these medicines
why the medicines work best when a person also makes lifestyle changes
More from Breastcancer.org Podcast
Actress Miranda McKeon was diagnosed with stage III breast cancer at age 19, just as she was starting her sophomore year of college. She talks about her experiences with diagnosis and treatment, as well as how she balanced presenting herself to her peers in a way that felt authentic when she was living an experience that was completely foreign to her.
Julia Maués didn’t decide to become an advocate, but her passion for patients learning science and scientists learning patient experiences propelled her to talk about her experiences.
Eleonora Teplinsky’s oncology practice has focused on people with breast cancer for more than a decade. Her new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer, explains breast cancer risks, screening, diagnosis, and treatment, as well as topics that may not be discussed by all doctors.
Dr. Luba Perry is the founder and CEO of ReConstruct Bio, where she’s working to develop bioengineered living tissue implants made from a person’s own cells that then integrate with the body as living tissue. The first goal is to develop natural implants for breast reconstruction.
An advocate and communications expert with more than 20 years experience in international corporate marketing, Christina Wilhelm wrote It’s Breast Cancer, Now What? as a manual to help people navigate breast cancer treatment, return-to-work, and long-term follow-up care decisions.